N ormal development of the fetal brain relies on an adequate oxygen supply, the lack of which has a great impact on the metabolism of neuronal cells. Many congenital heart diseases (CHDs) are associated with low cardiac output and can subsequently compromise the oxygen supply to the fetal brain. Fetuses can adapt to mild hypoxemia through blood redistribution, by means of vasodilatation of the cerebral arteries. However, when the hypoxemia is severe, permanent cell death will become inevitable. 1 Common abnormal findings in fetuses with CHD include increased cerebral blood flow, reduced brain fissures depth and brain volume, smaller head size, and structural brain abnormalities. [2] [3] [4] [5] [6] [7] [8] Volumes of brain regions containing large numbers of neurons are most likely to be affected. A recently published meta-analysis indicated that even in the absence of chromosomal anomalies, fetuses with CHD are still at increased risk of brain abnormalities. 9 About one-third of fetuses with transposition of the great arteries and half of fetuses with left-sided heart abnormalities were reported to have brain lesions on neuroimaging. 9, 10 Malformation or delay of cortical development and agenesis of the corpus callosum are among the most common brain abnormalities related to fetal CHD.
The cavum septi pellucidi (CSP) is a fluid-filled space in the fetal brain. It is bounded anteriorly, superiorly, and posteriorly by the corpus pellucidum, inferiorly by the fornix, and laterally by the septi pellucidi, respectively. On prenatal sonography, the CSP is an anechoic rectangular area on the axial view and can be visualized as early as 18 weeks' gestation. 11 The detection rate drops after 38 weeks. Visualization of the CSP is a critical step during fetal neurosonography. An absent CSP and a dilated CSP are two pathologic conditions that can be noticed on prenatal sonography. The former is mostly associated with midline fetal brain abnormalities such as agenesis of the corpus callosum, holoprosencephaly, and septo-optic dysplasia. [12] [13] [14] The latter has been mostly reported in fetuses with aneuploidies as well as 22q11.2 microdeletion (DeGeorge syndrome). [15] [16] [17] In fetuses with hypoplastic left heart syndrome (HLHS) and dextro-transposition of the great arteries (D-TGA), a decreased brain volume secondary to insufficient blood perfusion may cause CSP dilatation by reducing pressure on the CSP. In this study, the length and width of the CSP as well as the frontal lobe length were measured in healthy fetuses and fetuses with HLHS or D-TGA. We hypothesized that the dimensions of the CSP in fetuses with HLHS or D-TGA might be different from those in healthy fetuses.
Materials and Methods

Study Population and Procedures
This retrospective study enrolled prenatal cases referred to the Department of Obstetrics and Gynecology at Eastern Virginia Medical School between January 2005 and April 2016. The study population was composed of 3 groups: a control group of 185 singleton fetuses (404 scans) with normal sonographic findings and 2 CHD groups including 11 fetuses with HLHS (16 scans) and 11 fetuses with D-TGA (12 scans). Pregnancies complicated by any known chromosomal anomalies (by either conventional karyotyping, DNA microarray, or both) were excluded from the study.
When indications for a fetal intracranial anomaly (eg, ventriculomegaly) were present on sonography, operators would attempt to rule out partial agenesis of the corpus callosum by displaying the corpus callosum and pericallosal artery in the midsagittal view of the fetal brain. Partial agenesis of the corpus callosum would be suspected if either the entire corpus callosum could not be imaged or the pericallosal artery was missing. 18 When suspected, the patient would also be referred for fetal magnetic resonance imaging for further evaluation.
Every fetus in the normal group received scans within at least 2 of the following 3 gestational periods: (1) 14 weeks to 17 weeks 6 days; (2) 18 weeks to 27 weeks 6 days; and (3) after 28 weeks. Every fetus in the CHD group received 1 or 2 scans within the abovementioned periods. All scans were performed on Voluson E10, E8, and E6 diagnostic systems (GE Healthcare, Zipf, Austria). Data were stored and collected from a Viewpoint archive system (GE Healthcare, Solingen, Germany). An axial view of the fetal head used for biparietal diameter measurement was retrieved from each scan. This view must be symmetric and include the falx cerebri, CSP, thalamus, choroid plexus, and lateral ventricles. The following measurements were obtained from each image (Figure 1 ) for data analysis: (1) biparietal diameter; (2) width and length of the CSP; and (3) frontal lobe length. This study was approved by the Human Investigation Review Board at Eastern Virginia Medical School. 
Statistical Analysis
Sample characteristics and CSP measurements were summarized as means 6 standard deviations and tested for differences between the normal group and the CHD groups by 1-way analysis of variance after verifying the normality of data with the Kolmogorov-Smirnov test. To compare the size and position of the CSP between the control and CHD groups, multivariate analysis of covariance for repeated measures was used to properly account for the correlation among responses within a fetus while controlling for the biparietal diameter. As a secondary analysis, the relationship between each response measurement and the biparietal diameter was also assessed by a multivariate multiple regression adjusting for groups. Adjusted R 2 along with P values were reported to evaluate the linear association between the outcomes and biparietal diameter. Bland-Altman plots with 95% limits of agreement (LOA) were used to evaluate the interobserver and intraobserver repeatability for each measurement. All analyses were conducted with SAS version 9.4 software (SAS Institute Inc, Cary, NC). All results were considered statistically significant at P < .05.
Results
The fetal CSP width, CSP length, and frontal lobe length were successfully measured in the biparietal view from 404 scans in the control group. Twenty-two cases in the CHD groups were also included in this study (Table 1) . Of the 11 fetuses with a diagnosis of HLHS, 1 was complicated by total anomalous pulmonary vein connections; 2 were complicated by ventricular septal defects; 2 were complicated by single umbilical arteries; and 1 was complicated by a diaphragmatic hernia and hypospadias. Of the 11 fetuses with a diagnosis of D-TGA, 1 was complicated by coarctation of the aorta; 1 was complicated by cardiomyopathy; and 3 were complicated by small ventricular septal defects. No chromosomal anomalies were diagnosed in any of the 22 CHD cases. Table 2 shows the sample characteristics and CSP measurements for the control and CHD groups. The unadjusted results showed that only the CSP length was statistically different between the control group and the CHD groups (P 5 .0002). No significant difference was noticed in either the gestational age or biparietal diameter among the groups. Because fetuses with HLHS or D- Significant univariate effects were found for the CSP length and width but not for the frontal lobe length. The pair-wise comparisons using the Tukey-Kramer adjustment, as displayed in Table 3 , showed a significantly higher mean CSP length in both fetuses with HLHS and those with D-TGA compared to the healthy fetuses (P < .0001). However, the CSP width was found to be significantly higher only in the fetuses with D-TGA compared to the healthy fetuses (P 5 .0466). No statistically significant differences were found between the fetuses with respect to frontal lobe length (P > .05). Figures 2-4 show least squares mean plots comparing the healthy fetuses and those with CHD in terms of the CSP measurements.
The results of the multivariate regression analysis showed a strong positive linear association between CSP measurements (CSP length, CSP width, and frontal lobe length) and the biparietal diameter for each of the groups (normal, HLHS, and D-TGA; all P < .001). The adjusted R 2 values were 0.811, 0.821, and 0.878 for CSP length, CSP width, and frontal lobe length, respectively. The plots of the measurements in relation to the biparietal diameter for the different groups are displayed in Figures 5-7 . The analysis of the regression plots showed clearly that both the HLHS and D-TGA groups had higher CSP length and width scores across the range of biparietal diameters, whereas the fitted model for the frontal lobe length did not show a clear difference between the groups.
For each interobserver and intraobserver CSP measurement, a Bland-Altman plot was created to assess the reliability of the measurements. An analysis of the plots showed that most of the measurements were contained within the 95% LOA, and the mean differences (bias) did not substantially depart from 0. Table 4 displays the bias along with the 95% LOA for each measurement. These results suggested reliable repeatability of measurements with very minimal systematic error. Data are presented as mean 6 SD. BPD indicates biparietal diameter; GA, gestational age; and n, number of scans. a Significantly different from the control group. 
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Discussion
The CSP is a midline space filled with cerebrospinal fluid interposed between the laminae of the septi pellucidi. The CSP is formed at 12 to 14 weeks' gestation from the median groove and extended posteriorly when the posterior extension of the corpus callosum occurs. 19 On prenatal sonography, it can be visualized between the anterior horns of lateral ventricles. Previous studies indicated that the CSP could be effectively identified on sonography at 17 weeks gestation', although it might be visualized as early as 15 to 16 weeks. 20 With better sonographic resolution, a transvaginal approach, or both, our study revealed that the CSP could be imaged and measured as early as 14 to 15 weeks' gestation. Unavoidably, at this early gestational stage, the septum pellucidum, which separates the CSP from surrounding structures, can be confused with walls of lateral ventricles or the fornix. Therefore, a repeated evaluation in the mid second trimester is still required. Recently, evaluation of fetal intracranial anatomy has been attempted as early as the late first trimester to early second trimester. 21, 22 For this purpose, an understanding of normal fetal brain structures at this early stage of gestation becomes necessary.
The association between fetal CHD and brain development has been long reported in the past decade. Parameters used to evaluate fetal brain development included the fetal head circumference, brain volume, middle cerebral artery pulsatility index, cerebroplacental ratio, and brain fissure depth. Fetal hypoxemia might be a possible factor contributing to abnormal brain development in fetuses with CHD. In fetuses with an obstructed left outflow tract, reversed blood flow in the aortic arch can diminish the blood supply to the fetal brain via carotid arteries. In fetuses with D-TGA, the brain is perfused by low-oxygenated blood from the anatomic right ventricle. A study using magnetic resonance oximetry proved that both the cerebral oxygen level and brain volume were reduced in fetuses with CHD, including single-ventricle defects, tetralogy of Fallot, and D-TGA.
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Blood redistribution caused by decreased cerebrovascular resistance may protect the fetal brain from oxygen deprivation. Nevertheless, this process of adaption may be inadequate with regard to the rapid growth of the fetal brain in the second and third trimesters, causing a reduced brain volume and fissure depth. A recent nationwide cohort study revealed that most major CHD was associated with a smaller head circumference and a proportionally smaller birth weight z score, with the exception of D-TGA which had an asymmetrically smaller head circumference. Minor CHD, on the contrary, might have an increased head circumference relative to birth weight. These findings indicate that additional mechanisms, other than hypoxemia, such as genetic and placental causes, may also result in abnormal brain development associated with CHD except D-TGA. 23 Also, if fetal hypoxemia is the real cause of the abnormal findings in the fetal central nervous system, one may expect to see similar findings in fetuses with severe intrauterine growth restriction. However, no such study has been conducted. The latest research found that sustained maternal hyperoxygenation may improve aortic arch dimensions in fetuses with coarctation. 24 This novel finding is very encouraging, since an increased size of the aortic arch could prompt oxygen delivery to the fetal brain and ultimately change the neurodevelopmental outcome.
Visualization of the CSP is a critical step in evaluation of fetal brain anatomy during fetal neurosonography. Usually, the CSP stays patent throughout the whole fetal life and closes at 3 to 6 months after birth, secondary to the rapid growth of surrounding structures. Only less than 4% of children at the age of 1 year still have the CSP visible on computed tomography. 25 A persistent CSP has been associated with traumatic brain injury and schizophrenia 26, 27 Prenatally, an enlarged CSP has been associated with chromosomal anomalies, including 15 An abnormally shaped wide and short CSP with a decreased CSP length-to-width ratio was also found to be associated with fetal partial agenesis of the corpus callosum. 28 No explanation has been provided yet in prior studies regarding the shape change of the CSP in fetal aneuploidy, 22q11 microdeletion, or partial agenesis of the corpus callosum. To the best of our knowledge, this work was the first study focusing on the relationship between the CSP and CHD. The underlying mechanism for this phenomenon is unclear. Based on our study, both the length and width of the CSP are increased in fetuses with HLHS. In fetuses with HLHS, the left ventricle is underdeveloped, and its contractility is also compromised. No or a less-than-normal amount of blood is pumped to the ascending aorta. As a result, oxygen delivered to the brain through the aorta is restricted, which may lead to a reduced brain volume. 6 This change can reduce the pressure on the CSP from surrounding brain tissue, causing the CSP to expand and producing larger measurements in both length and width. Similar findings are also noted in fetuses with D-TGA when the aorta is receiving low-oxygenated blood from the anatomic right ventricle.
Prior studies also reported that more than half of fetuses with trisomy 21 had frontothalamic distance shortening. 29, 30 The length of the frontothalamic distance may be affected by the frontal lobe, CSP, or thalamus. In our study, we measured the frontal lobe length, which reflects the anteroposterior dimension of the frontal lobe. Interestingly, our results showed that neither fetuses with HLHS nor fetuses with D-TGA had frontal lobe length shortening. This finding could be explained by the fact that the frontal lobe may be better protected from oxygen deprivation due to vasodilatation in the territory of the anterior cerebral artery. 31 An increase in the length of the CSP may be due to decreased volumes of other portions of the brain.
Our study had some limitations. First, because of the retrospective nature of the study, we were unable to perform more detailed measurements, such as the volumes of the CSP and its adjacent structures. Second, the difference in CSP measurements between healthy fetuses and fetuses with HLHS or D-TGA was relatively small. Although the difference was statistically significant, overlap between the cases and controls may still limit its application in clinical settings. Third, although we tried to exclude partial agenesis of the corpus callosum, it was technically difficult to identify those cases on prenatal sonography. Last, the sample size was relatively small, especially for the CHD cases.
To conclude, this study reveals that the dimensions of the CSP are increased in fetuses with HLHS or D-TGA. These changes may be indicative of a reduced cortical brain volume, which could have an impact on postnatal cognitive development. Further studies will be needed to investigate the correlation between the CSP size and brain volume in fetuses with certain CHD.
